Skip to Main Content

Author Details

Huihui Ye
College of Optical Science and Engineering, Zhejiang University
2004
82
31
PMIDPaper TitleJournal TitlePublished Year
36629336Optimized three-dimensional ultrashort echo time: Magnetic resonance fingerprinting for myelin tissue fraction mapping.Hum Brain Mapp2023
35050902Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci.JCI Insight2022
35377841Accelerated MRI Reconstruction With Separable and Enhanced Low-Rank Hankel Regularization.IEEE Trans Med Imaging2022
35436357Blip up-down acquisition for spin- and gradient-echo imaging (BUDA-SAGE) with self-supervised denoising enables efficient T<sub>2</sub> , T<sub>2</sub> *, para- and dia-magnetic susceptibility mapping.Magn Reson Med2022
35393570TMPRSS2-ERG promotes the initiation of prostate cancer by suppressing oncogene-induced senescence.Cancer Gene Ther2022
36248777Scrotal fibrous hamartoma of infancy: A case report and literature review of a rare tumor of the genitourinary tract.Urol Case Rep2022
36128328Targeting Krebs-cycle-deficient renal cell carcinoma with Poly ADP-ribose polymerase inhibitors and low-dose alkylating chemotherapy.Oncotarget2022
36086452Improved Balanced Steady-State Free Precession Based MR Fingerprinting with Deep Autoencoders.Annu Int Conf IEEE Eng Med Biol Soc2022
35132367Donor-Derived Urothelial Carcinoma in Renal Transplant Recipients.Case Rep Urol2022
35075215Effects of dietary omega-3 fatty acids on orthotopic prostate cancer progression, tumor associated macrophages, angiogenesis and T-cell activation-dependence on GPR120.Prostate Cancer Prostatic Dis2022
35131873Autocrine Canonical Wnt Signaling Primes Noncanonical Signaling through ROR1 in Metastatic Castration-Resistant Prostate Cancer.Cancer Res2022
35253922An efficient approach to optimal experimental design for magnetic resonance fingerprinting with B-splines.Magn Reson Med2022
35180608Yolk sac differentiation in urothelial carcinoma - A rare variant originating from aberrant differentiation of sarcomatoid components.Ann Diagn Pathol2022
33023952Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response.Clin Cancer Res2021
33601084A multi-resolution model for histopathology image classification and localization with multiple instance learning.Comput Biol Med2021
33683939Results of a Randomized Phase II Trial of Intense Androgen Deprivation Therapy prior to Radical Prostatectomy in Men with High-Risk Localized Prostate Cancer.J Urol2021
33899001EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer.Nat Cancer2021
33785256Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy.Eur Urol2021
33932081Phosphorylation of the androgen receptor at Ser81 is co-sustained by CDK1 and CDK9 and leads to AR-mediated transactivation in prostate cancer.Mol Oncol2021
34638229Current Applications and Future Development of Magnetic Resonance Fingerprinting in Diagnosis, Characterization, and Response Monitoring in Cancer.Cancers (Basel)2021
34564012Corrigendum to "Quantitative MR relaxation using MR fingerprinting with fractional-order signal evolution" [J. Magn. Reson. 330 (2021) 107042].J Magn Reson2021
34333244Quantitative MR relaxation using MR fingerprinting with fractional-order signal evolution.J Magn Reson2021
32461072Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate Cancer.Eur Urol2020
32054861A case report of multiple primary prostate tumors with differential drug sensitivity.Nat Commun2020
30439513Rigid motion correction for magnetic resonance fingerprinting with sliding-window reconstruction and image registration.Magn Reson Imaging2019
31666198Primary adenocarcinoma of the bladder lacks mismatch repair deficiency and demonstrates PD-L1 expression in tumor-infiltrating immune cells, with implications in both diagnosis and therapeutics.Hum Pathol2019
30811282Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone.J Clin Oncol2019
30914763Comparing histologic evaluation of prostate tissue using nonlinear microscopy and paraffin H&amp;E: a pilot study.Mod Pathol2019
30883867Fast 3D brain MR fingerprinting based on multi-axis spiral projection trajectory.Magn Reson Med2019
31131911Ultrashort echo time magnetic resonance fingerprinting (UTE-MRF) for simultaneous quantification of long and ultrashort T<sub>2</sub> tissues.Magn Reson Med2019
28411394Improved magnetic resonance fingerprinting reconstruction with low-rank and subspace modeling.Magn Reson Med2018
32914001Case of Basal Cell Carcinoma of the Prostate Successfully Treated Before and After a <i>BRCA2</i> Reversion Mutation.JCO Precis Oncol2018
29916782Detection of Lesions in Mesial Temporal Lobe Epilepsy by Using MR Fingerprinting.Radiology2018
30242112Downregulation of <i>Dipeptidyl Peptidase 4</i> Accelerates Progression to Castration-Resistant Prostate Cancer.Cancer Res2018
30217568Phosphorylation of androgen receptor serine 81 is associated with its reactivation in castration-resistant prostate cancer.Cancer Lett2018
30103901Molecular correlates of intermediate- and high-risk localized prostate cancer.Urol Oncol2018
29993630Squeezed Trajectory Design for Peak RF and Integrated RF Power Reduction in Parallel Transmission MRI.IEEE Trans Med Imaging2018
30208947Alpha-fetoprotein (AFP) as tumor marker in a patient with urothelial cancer with exceptional response to anti-PD-1 therapy and an escape lesion mimic.J Immunother Cancer2018
30012673BMX-Mediated Regulation of Multiple Tyrosine Kinases Contributes to Castration Resistance in Prostate Cancer.Cancer Res2018
29983878Prostate cancer susceptibility gene <i>HIST1H1A</i> is a modulator of androgen receptor signaling and epithelial to mesenchymal transition.Oncotarget2018
29921690Neoadjuvant-Intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci with Diverse Subclonal Oncogenic Alterations.Cancer Res2018
27220881Simultaneous multislice magnetic resonance fingerprinting (SMS-MRF) with direct-spiral slice-GRAPPA (ds-SG) reconstruction.Magn Reson Med2017
28435102Simultaneous Time Interleaved MultiSlice (STIMS) for Rapid Susceptibility Weighted acquisition.Neuroimage2017
28274958Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity.Cancer Discov2017
28119368Gleason Score 7 Prostate Cancers Emerge through Branched Evolution of Clonal Gleason Pattern 3 and 4.Clin Cancer Res2017
28674429Citrate Suppresses Tumor Growth in Multiple Models through Inhibition of Glycolysis, the Tricarboxylic Acid Cycle and the IGF-1R Pathway.Sci Rep2017
28893901Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide.Clin Cancer Res2017
28019022Use of pattern recognition for unaliasing simultaneously acquired slices in simultaneous multislice MR fingerprinting.Magn Reson Med2017
27851871Robust sliding-window reconstruction for Accelerating the acquisition of MR fingerprinting.Magn Reson Med2017
28062857Positive feedback loop mediated by protein phosphatase 1α mobilization of P-TEFb and basal CDK1 drives androgen receptor in prostate cancer.Nucleic Acids Res2017
  • 1 - 50 of 82

Recommended Authors

Simpa S Salami
University of Michigan Medical School ann arbor
Career Start Year 2012
Number of shared co-authors 32
Steven Hazell
Royal Marsden NHS Foundation Trust
Career Start Year 2011
Number of shared co-authors 1
Adam Kinnaird
University of Alberta
Career Start Year 2007
Number of shared co-authors 8
Roula Albadine
Centre hospitalier de l'Universite de Montreal
Career Start Year 2006
Number of shared co-authors 4
Michelle R Downes
University of Toronto
Career Start Year 2006
Number of shared co-authors 3
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 33
Amirali Salmasi
University of California San Diego
Career Start Year 2005
Number of shared co-authors 9
Robert H Bell
University of British Columbia
Career Start Year 2004
Number of shared co-authors 12
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Career Start Year 2003
Number of shared co-authors 45
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 6
Lakshmi P Kunju
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2002
Number of shared co-authors 30
Chantal Pauli
University Hospital Zurich
Career Start Year 2001
Number of shared co-authors 14
Mathieu Latour
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2001
Number of shared co-authors 13
Jiaoti Huang
Duke University School of Medicine
Career Start Year 2000
Number of shared co-authors 31
Anuradha Gopalan
Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 27
Rohit Mehra
Michigan Center for Translational Pathology.
Career Start Year 2000
Number of shared co-authors 49
Hayley C Whitaker
University College London
Career Start Year 1999
Number of shared co-authors 6
Geert J L H van Leenders
Erasmus MC Cancer Institute, University Medical Center
Career Start Year 1998
Number of shared co-authors 8
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 7
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 12
Andrew J Evans
Princess Margaret Cancer Center, University Health Network.
Career Start Year 1996
Number of shared co-authors 7
David Clouston
Career Start Year 1995
Number of shared co-authors 6
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 21
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
Marshall Scott Lucia
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 6
Anders Bjartell
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 21
Dominique Trudel
Institut du cancer de Montreal
Career Start Year 1985
Number of shared co-authors 10
David M Berman
Queen's University
Career Start Year 1982
Number of shared co-authors 19
Daniel M Berney
Barts Cancer Institute, Queen Mary University of London
Career Start Year 1975
Number of shared co-authors 13
Theodorus H van der Kwast
University Health Network, University of Toronto
Career Start Year 1974
Number of shared co-authors 32

Collaborators

Steven P Balk
Beth Israel Deaconess Medical Center and Harvard Medical School
Co-authored papers 16
Adam G Sowalsky
National Cancer Institute
Co-authored papers 14
Rosina T Lis
National Cancer Institute
Co-authored papers 9
Mary-Ellen Taplin
Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute
Co-authored papers 9
Bruce Montgomery
Fred Hutchinson Cancer Center, University of Washington
Co-authored papers 5
Peter S Nelson
Fred Hutchinson Cancer Center
Co-authored papers 5
Massimo Loda
Weill Medical College of Cornell University
Co-authored papers 5
Changmeng Cai
Center for Personalized Cancer Therapy, University of Massachusetts Boston
Co-authored papers 5
Elahe A Mostaghel
University of Washington
Co-authored papers 4
Fadi Brimo
McGill University Health Centre, McGill University
Co-authored papers 3
Maria J Merino
National Cancer Institute, National Institutes of Health
Co-authored papers 3
Stephanie A Harmon
National Cancer Institute, National Institutes of Health
Co-authored papers 3
Peter L Choyke
National Cancer Institute, National Institutes of Health
Co-authored papers 3
Philip W Kantoff
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Tamara L Lotan
Johns Hopkins University School of Medicine
Co-authored papers 3
Baris Turkbey
National Cancer Institute, National Institutes of Health
Co-authored papers 3
Shuai Gao
Center for Personalized Cancer Therapy, University of Massachusetts Boston
Co-authored papers 2
Tristan Grogan
University of California Los Angeles
Co-authored papers 2
Arul M Chinnaiyan
University of Michigan Medical School.
Co-authored papers 2
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 2
Paul C Boutros
University of California los angeles
Co-authored papers 2
Eliezer M Van Allen
Dana-Farber Cancer Institute
Co-authored papers 2
Mark A Rubin
University of Bern
Co-authored papers 2
Olivier Elemento
Meyer Cancer Center
Co-authored papers 2
Ashley E Ross
Northwestern University
Co-authored papers 2
Theresa Y MacDonald
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 2
David Elashoff
David Geffen School of Medicine at University of California los angeles
Co-authored papers 2
Brian J Capaldo
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Kyung Park
New York University Langone Health
Co-authored papers 2
Housheng Hansen He
Princess Margaret Cancer Center, University Health Network, University of Toronto
Co-authored papers 2
Release 1.2